IM Cannabis Corp.

IMCC • Drug Manufacturers - Specialty & Generic

$1.98

— 0.00 (0.00%)

EarningsLatest report: Jun 30, 2026

HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology

Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.

Market Cap

$18.35M

Growth

-11.5%

Cash Flow

1/5

Trend

Volatile

Evidence

Positive free cash flow · 1.11Weak liquidity · 0.67Weak profitability

Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 19, 2026, 12:24 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$1.98

Change0.00%

Shares Out9.27M

Market Cap$18.35M

52W Range0.09 - 2.61

Beta2.06

P/E-8.68

P/S9.11

P/B-11.41

P/FCF-139.59

EV/Sales2.66

EV/EBITDA-19.61

Price$1.98

Change0.00%

Shares Out9.27M

Market Cap$18.35M

52W Range0.09 - 2.61

Beta2.06

P/E-8.68

P/S9.11

P/B-11.41

P/FCF-139.59

EV/Sales2.66

EV/EBITDA-19.61

EV/FCF-40.82

Earnings Yield-2.88%

FCF Yield-0.72%

Dividend Yield0.00%

Gross Margin17.70%

Oper. Margin-21.17%

Profit Margin-20.68%

Debt/Eq-18.96

Current Ratio0.67

Quick Ratio0.54

Revenue 5Y-11.46%

Volume1.13M

Avg Volume4.37M

EPS Surprise-0.95

Investment DNA

How strong this company looks for long-term investors

out of 100

Business Quality

Margins, moat, returns

22/100

Financial Strength

Debt, cash, stability

20/100

Growth Potential

Revenue and expansion

62/100

Price Attractiveness

Cheap or expensive today

95/100

Why this score▼

Positive free cash flow · 1.11Weak liquidity · 0.67Weak profitability

Analyst view

Analyst sentiment and price target

IMCC

Analyst sentiment

Based on 1 analyst votes · 2026-09-05

100/100

Bullish

Hold

Bearish

Company Overview

IPO: 5/20/2020

Industry: Drug Manufacturers - Specialty & Generic

P/B i: -11.41

Debt / Equity i: -18.96

Operating Margin: -21.17%

Net Margin: -20.68%

ROE i: -

ROIC: -

Financial Health

Score4 / 20

Debt / Equity: -18.96

Current Ratio: 0.67

Quick Ratio: 0.54

Status: HighRisk

Warnings

Weak Liquidity
Weak quick ratio

🧾

No insider activity

No recent insider transactions available.

About the Company

IM Cannabis Corp.

IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods throughout international markets such as Israel, Germany, and Canada. The company offers a range of cannabis products, including flowers and specifically formulated cannabis extracts, marketed under its IMC brand. Furthermore, it supplies dried flower, pre-rolled products, and compressed hashish via its WAGNERS and Highland Grow labels. IM Cannabis Corp. serves a broad customer base, addressing the needs of both medical patients and adult recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.

Source - link

Peers

AKAN FLGC GRI JAGX MOVE NAOV NDRA RDHL SHPH VERO

Size reflects market cap · color matches the chart line

1Y peer performance

Top performers + selected company

Latest news

IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing

TORONTO and GLIL YAM, Israel, Sept. 2, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMCC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced the closing of a US$225,000 convertible note financing in a private placement with an institutional investor (the "Lender").

PRNewsWire

IM Cannabis Shares Commence Trading on 30:1 Consolidated Basis

TORONTO and GLIL YAM, Israel, Aug. 27, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, announces that, further to its press release dated August 18, 2026, the Company's common shares, no par value per share ("Common Shares"), commenced trading today on the Nasdaq Capital Market LLC ("Nasdaq") on a 30:1 post-consolidated basis (the "Consolidation"). The Company's existing trading symbol "IMCC" remains unchanged.

PRNewsWire

IM Cannabis Announces Intention to Complete 30:1 Share Consolidation to Support Nasdaq Minimum Bid Price Compliance

TORONTO and GLIL YAM, Israel, Aug. 18, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, announces that the board of directors of the Company (the "Board") has approved a consolidation of its issued and outstanding common shares, no par value per share ("Common Shares") on the basis of one post-consolidated Common Share for every thirty pre-consolidated Common Shares (the "Consolidation"). The Board has authorized the Consolidation to be effected on or before September 15, 2026, with the Company currently expecting August 27, 2026 to be the effective date of the Consolidation (the "Effective Date").

PRNewsWire

IM Cannabis Leverages Restructuring Deal to Reduce Financial Strain

IM Cannabis Corp. (NASDAQ:IMCC) on Monday agreed to divest its subsidiary IMC Holdings Ltd. to Slil.com Holding Ltd.

Benzinga

IM Cannabis Enters into Agreement to Sell IMC Holdings and European- Focused Assets

Transaction Expected to Result in an Improvement of Approximately CAD$3 million in Shareholders' Equity TORONTO and GLIL YAM, Israel, Aug. 17, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), today announced that, further to its press release dated June 18, 2026, it has entered into a definitive share purchase agreement dated August 16, 2026 (the "Share Purchase Agreement") with Slil.com Holding Ltd. ("Slil") and I.M.C.

PRNewsWire

Earnings Surprises

Period	Estimate	Actual	Surprise
2026-03-30	0.08596	-0.86	-0.94596
2025-11-13	-0.02313	-0.54	-0.51687
2025-08-12	-0.13668	-0.07	0.06668
2025-05-15	-0.25468	0.06	0.31468
2025-03-31	-0.39	-0.23	0.16
2024-11-14	-0.7	-0.3	0.4
2024-08-14	-0.84	-0.17	0.67
2024-05-08	-0.96	-0.96	0
2024-03-28	-0.96	-1.08	-0.12
2023-11-13	-0.96	-0.72	0.24
2023-08-14	-0.78	-1.14	-0.36
2023-05-15	-1.2	0.12	1.32